Stock Day Media

Innovent Biologics, Inc. | Fifty 1 Labs, Inc.

Jun 20, 2024 · 0m

<div>Innovent Biologics, Inc. (HKEX: 01801), a world-class biopharmaceutical company announced that clinical data of IBI363 (first-in-class PD-1/IL-2 α-bias bispecific antibody fusion protein) in advanced solid tumors are presented at the 2024 ESMO Virtual Plenary.<br> <br> Fifty 1 Labs, Inc. (OTCPK: CAFI), a holding company that operates in the sports supplement, fitness equipment, and health and wellness industries is pleased to provide an update to its shareholders regarding recent strategic initiatives and significant developments within the company. Over the past several …

Denna episod har inte transkriberats ännu

Använd STT.ai för att transkribera denna episod med AI. Få exakt text med högtalardetektering, tidsstämpel och export i flera format.

Ändra denna avsnitt

Högtalardetektering Tidstämpel på ordnivå Export som SRT, TXT, JSON

Fler avsnitt

Innovent Biologics, Inc. | Fifty 1 Labs, Inc.

Denna episod har inte transkriberats ännu

Fler avsnitt

Viper Networks: Connecting the Unconnected with Innovative Solutions

Revolutionizing Investment: Mobi Card's Game-Changing Updates

Husqvarna | Delta Apparel, Inc.

Scheid Vineyards Inc. | Royal Road Minerals

Navidea Biopharmaceuticals, Inc. | Ekinops

Innovent Biologics, Inc. | MAX Power Mining Corp.

NuRAN Wireless Inc. | Robotic Assistance Devices, Inc.

Laredo Oil, Inc. | BlockQuarry Corp.

DEEPX | EACO Corporation

PCS Edventures!, Inc. | Right On Brands, Inc.